Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan Kerastick and Blue Light for Actinic Keratosis
NCT03024060Phase 3Withdrawn
- Sponsor
- DUSA Pharmaceuticals
- Start
- Mar 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by DUSA Pharmaceuticals. Planned start Mar 2017; status: withdrawn.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03024060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024060.